Medical equipment makers aim for UK

England's medical equipment market is worth approximately $6 billion.

By MATTHEW KRIEGER
March 12, 2007 11:30

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

A group of Israeli CEOs whose companies manufacture medical equipment travelled to England last week to meet with investors and hospital representatives in the hope of expanding their businesses into the British market, the world's sixth largest market of health-care services. England's medical equipment market is worth approximately $6 billion, according to the National Health Service, England's national health care provider. Israel and England did over $4b. worth of trade in 2006, with Israeli exports mainly consisting of plastics, and agricultural and communications equipment. Exports of medical supplies grew 35% in 2006 to $32 million, according to the Ministry of Industry, Trade and Labor.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS